Drug Type Synthetic peptide |
Synonyms- |
Action- |
Mechanism CD19 stimulants(B-lymphocyte antigen CD19 stimulants), HER2 stimulants(Receptor protein-tyrosine kinase erbB-2 stimulants), IL-3 stimulants(interleukin 3 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | - | 20 Feb 2024 |





